A new bone marrow imaging technique could change treatment for cancer, autoimmune disease and musculoskeletal disorders.

Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast glioma recurrence with up to 89 percent accuracy.

Enables medical professionals to observe skin without removing dressings; aims to reduce secondary infections and save time ...

(Nasdaq: HOLX) will have a strong presence at the Society of Breast Imaging (SBI) Annual Symposium in Colorado Springs, ...

Nearly 150 years ago, scientists began to imagine how information might flow through the brain based on the shapes of neurons ...

Turner Imaging Systems (TIS), a trailblazer in portable X-ray technology, today announced its acceptance into the NVIDIA ...

Medical Center-Ontario on April 16 announced the arrival of the Altea MR system, a new MRI technology focused on better ...

One promising technique – mass spectrometry imaging – overcomes some of these challenges. It allows researchers to see ...

The medical imaging industry is a somewhat consolidated oligopoly, with the top three players GEHC, Siemens Healthineers, and Philips controlling about 70% of the market. They largely compete by ...

Ultrasound imaging is one of the most widely used diagnostic tools in modern medicine. Behind its noninvasive magic lies a ...

Magnets are complex, costly MRI components; Paras is playing a key role in reducing import dependency, and making advanced ...

Healthcare is ever-changing, as it has been for decades. Sometimes, these changes are for the better, while other times, they may be for the worse. Becker’s connected with several physicians across a ...